We are live on
!
Find out more
Rafferty Asset Management Portfolio holdings
AUM
$24.6B
1-Year Est. Return
47.06%
This Fund
S&P 500
This Quarter
Est. Return
-17.24%
1 Year Est. Return
+47.06%
3 Year Est. Return
+108.18%
5 Year Est. Return
+135.84%
10 Year Est. Return
+427.13%
AUM
$10.9B
AUM Growth
-$6B
(-36%)
Cap. Flow
-$3.12B
Cap. Flow
% of AUM
-28.68%
Top 10 Holdings %
Top 10 Hldgs %
39.15%
Holding
1,272
New
54
Increased
189
Reduced
877
Closed
147
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares China Large-Cap ETF
FXI
|
+$98.6M |
| 2 |
KraneShares CSI China Internet ETF
KWEB
|
+$28.5M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$23.8M |
| 4 |
Texas Instruments
TXN
|
+$9.35M |
| 5 |
VTNR
Vertex Energy, Inc
VTNR
|
+$8.18M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$612M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$211M |
| 3 |
Microsoft
MSFT
|
+$102M |
| 4 |
Broadcom
AVGO
|
+$90M |
| 5 |
Qualcomm
QCOM
|
+$84.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.25% |
| 2 | Financials | 12.23% |
| 3 | Energy | 7.74% |
| 4 | Healthcare | 5.49% |
| 5 | Industrials | 2.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Amphenol
APH
$197B
| $4.42M | 0.04% |
137,376
-77,928
| -36% | -$2.71M |
|
302
Ionis Pharmaceuticals
IONS
$8.85B
| $4.42M | 0.04% |
119,283
-59,511
| -33% | -$2.24M |
|
303
First Citizens BancShares
FCNCA
$24.6B
| $4.39M | 0.04% |
6,708
-4,787
| -42% | -$3.12M |
|
304
Exelixis
EXEL
$14.1B
| $4.38M | 0.04% |
210,465
-44,282
| -17% | -$913K |
|
305
Brown & Brown
BRO
$23.7B
| $4.38M | 0.04% |
75,082
-42,907
| -36% | -$2.63M |
|
|
MRTX
306
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $4.34M | 0.04% |
64,664
-1,537
| -2% | -$97.7K |
|
|
SWTX
307
DELISTED
SpringWorks Therapeutics
SWTX
| $4.3M | 0.04% |
174,704
+83,875
| +92% | +$3.07M |
|
308
Bristol-Myers Squibb
BMY
$132B
| $4.22M | 0.04% |
54,814
-18,154
| -25% | -$1.38M |
|
309
BioMarin Pharmaceuticals
BMRN
$11.7B
| $4.21M | 0.04% |
50,821
-19,562
| -28% | -$1.56M |
|
310
Vir Biotechnology
VIR
$1.5B
| $4.21M | 0.04% |
165,167
-79,670
| -33% | -$1.86M |
|
|
APLS
311
DELISTED
Apellis Pharmaceuticals
APLS
| $4.2M | 0.04% |
92,889
-30,606
| -25% | -$1.4M |
|
312
TE Connectivity
TEL
$59.9B
| $4.19M | 0.04% |
37,058
-21,495
| -37% | -$2.66M |
|
313
Alkermes
ALKS
$8.39B
| $4.19M | 0.04% |
140,514
-80,530
| -36% | -$2.31M |
|
314
Lowe's Companies
LOW
$118B
| $4.18M | 0.04% |
23,945
-14,531
| -38% | -$2.8M |
|
315
iShares Global Clean Energy ETF
ICLN
$2.33B
| $4.17M | 0.04% |
219,097
-77,478
| -26% | -$1.51M |
|
316
Zions Bancorporation
ZION
$10.1B
| $4.16M | 0.04% |
81,759
-52,831
| -39% | -$3M |
|
317
BridgeBio Pharma
BBIO
$16.1B
| $4.11M | 0.04% |
453,080
-170,122
| -27% | -$1.42M |
|
318
BioCryst Pharmaceuticals
BCRX
$2.35B
| $4.1M | 0.04% |
387,327
+55,614
| +17% | +$574K |
|
319
Western Alliance Bancorporation
WAL
$8.87B
| $4.09M | 0.04% |
57,993
-40,225
| -41% | -$3.08M |
|
320
United Therapeutics
UTHR
$26.2B
| $4.09M | 0.04% |
17,347
-13,563
| -44% | -$2.76M |
|
321
Arista Networks
ANET
$215B
| $4.08M | 0.04% |
173,968
-76,740
| -31% | -$2.1M |
|
322
Editas Medicine
EDIT
$413M
| $4.06M | 0.04% |
343,099
-11,964
| -3% | -$160K |
|
323
Webster Financial
WBS
$12.5B
| $4.04M | 0.04% |
95,968
-62,713
| -40% | -$3.02M |
|
324
Prologis
PLD
$136B
| $4.04M | 0.04% |
34,362
-6,090
| -15% | -$842K |
|
325
Motorola Solutions
MSI
$71.5B
| $4.03M | 0.04% |
19,245
-9,349
| -33% | -$2.04M |
|
Similar funds
CS
AF
SC
JG
Rafferty Asset Management's Q2 2022 Portfolio in Review
As of Q2 2022, Rafferty Asset Management held 1,272 positions worth $10.9B, down 36% from $16.9B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Rafferty Asset Management withdrew a net $3.12B in Q2 2022, closing 147 positions and reducing 877 holdings. Its most notable exit was Xtrackers Harvest CSI 300 China A-Shares ETF, an estimated $24.8M position sold in full.
By sector, the portfolio is most concentrated in Technology at 34% of assets, down from 36% a quarter earlier, followed by Financials and Energy.
Against the trend, Rafferty Asset Management opened a new position in Vertex Energy, Inc worth $7.26M.
- Rafferty Asset Management's largest Q2 2022 buy was Vertex Energy, Inc: 690,301 shares worth $7.26M.
- Rafferty Asset Management added most to iShares China Large-Cap ETF in Q2 2022, an estimated $98.6M increase.
- Rafferty Asset Management's biggest Q2 2022 reduction was iShares Core S&P 500 ETF, cutting an estimated $612M.
- Rafferty Asset Management fully exited Xtrackers Harvest CSI 300 China A-Shares ETF in Q2 2022, selling an estimated $24.8M.
- Rafferty Asset Management's ten largest holdings make up 39% of its $10.9B portfolio in Q2 2022.
- Rafferty Asset Management opened 54 new positions and closed 147 in Q2 2022.
- Rafferty Asset Management's portfolio value fell 36% quarter-over-quarter to $10.9B.
Based on Rafferty Asset Management's 13F filing for Q2 2022, filed 12 Aug 2022.